Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Enbridge Receives Higher Price Target as Cash Flow Outlook Remains Strong Indias Petroleum Product Export Share Dips to 88 in FY26 Lowest in Over a Decade USChina Trade Tensions Persist at APEC Three Signs of Lingering Differences Nvidias Blockbuster Earnings Reveal 200 Billion Edge Computing Opportunity Amid China Market Shift ADP Private Payrolls Rise 109000 in April Exceeding Expectations Fed Rate Cut Hopes Diminish SPOT Q1 2026 Earnings EPS Surges Past Estimates Stock Jumps 6 Vertex Inc VERX Q1 2026 Earnings Slight EPS Beat Lifts Shares Despite Unclear Revenue Picture Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings WiderThanExpected Loss as Clinical Pipeline Progresses ASTH Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction eBay Q1 2026 Earnings EPS Beat Slightly Overshadowed by Subdued Market Reaction Ranpak Holdings PACK Posts 18 Gain Approaches Key Resistance Level CTS Corporation CTS Surges 402 Key Levels to Monitor Here Group Limited HERE Slips 26 Testing Key Support Zone BlackRock MultiSector Income Trust BIT Edges Higher as IncomeSeeking Investors Rotate into FixedIncome CEFs China Tightens CrossBorder Stock Trading Regulations Key Details Berkshire Hathaway Builds 26 Billion Stake in Delta Air Lines Reversing PandemicEra Exit Broadcom Meta Applied Materials GlobalFoundries Synopsys Launch 125 Million Semiconductor Hub at UCLA Chinas Robot Workforce Prep How the Nation Is Training Machines for Industrial Dominance TPVG Q1 2026 Earnings Net Investment Income Misses Estimates as Stock Edges Higher JCAP Q1 2026 Earnings EPS Beat Defies Market Expectations Despite Slight Stock Dip ZETA Q1 2026 Earnings Strong EPS Beat Drives Optimism Despite Modest Stock Pullback MOMO Q4 2025 Earnings EPS Misses Estimates Shares Edge Lower RMCO Q4 2025 Earnings Significant EPS Miss as Company Reports Loss DFTX Q1 2026 Earnings EPS Misses Estimates by 4143 as PreRevenue Biotech Reports Wider Loss